Biogen Inc. (BIIB)

Sector:Health Care
Super Investor Stats:
Ownership count:2
Ownership rank:342
% of all portfolios:0.063%
Hold Price * :$173.13
History Portfolio Manager Activity ▲ Share change % change to portfolio
Q3  2024
≡ Samantha McLemore - Patient Capital Management Reduce 0.52% 1,327 0.01
Q1  2024
≡ Lee Ainslie - Maverick Capital Sell 100.00% 1,600 0.01
Q3  2023
≡ Lee Ainslie - Maverick Capital Sell 100.00% 983 0.01
Q3  2022
≡ Hillman Value Fund Reduce 37.25% 10,839 1.67
Q2  2022
≡ Mason Hawkins - Longleaf Partners Sell 100.00% 337,077 4.24
Q4  2021
≡ Lee Ainslie - Maverick Capital Sell 100.00% 3,112 0.01
Q3  2021
≡ Bill Miller - Miller Value Partners Sell 100.00% 79,493 0.72
Q2  2021
≡ Warren Buffett - Berkshire Hathaway Sell 100.00% 643,022 0.07
≡ Mason Hawkins - Longleaf Partners Sell 100.00% 249,422 4.59
Q4  2020
≡ Lee Ainslie - Maverick Capital Sell 100.00% 1,436 0.01
Q3  2020
≡ Lee Ainslie - Maverick Capital Reduce 68.10% 3,065 0.02
≡ First Eagle Investment Management Sell 100.00% 57,300 0.05
Q1  2020
≡ Warren Buffett - Berkshire Hathaway Reduce 0.84% 5,425 0.00
Q4  2019
≡ Lee Ainslie - Maverick Capital Sell 100.00% 4,919 0.02
Q1  2019
≡ Michael Burry - Scion Asset Management Sell 100.00% 10,000 2.91
Q3  2017
≡ Lee Ainslie - Maverick Capital Sell 100.00% 15,230 0.05
Q1  2017
≡ Lee Ainslie - Maverick Capital Reduce 11.67% 1,270 0.00
Q3  2016
≡ Lee Ainslie - Maverick Capital Reduce 5.72% 630 0.00

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.